Facilitating Access to Approved Medication

deucravacitinib tablets
Deucravacitinib, is a TYK2 inhibitor used for the treatment of moderate to severe plaque psoriasis. It was developed by Bristol Myers Squibb. It acts as a highly selective allosteric inhibitor of non-receptor tyrosine-protein kinase 2 (TYK2).

Get Access To deucravacitinib tablets

Ribociclib-tablets Available Price In India UK Saudi Arabia

deucravacitinib Tablets

  • API: deucravacitinib
  • Packaging: Tablets
  • Strength: 6 mg Tablets


Deucravacitinib is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).  Active ingredient: deucravacitinib. Inactive ingredients: anhydrous lactose, croscarmellose sodium, hypromellose acetate succinate, magnesium stearate, microcrystalline cellulose and silicon dioxide. In addition, the film coating Opadry® II Pink contains the following inactive ingredients: polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, iron oxide red and yellow.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. deucravacitinib tablets is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.